£108.00

Springer Chemo Fog: Cancer Chemotherapy Cognitive Impairment

Name: Springer Chemo Fog: Cancer Chemotherapy Cognitive Impairment
Brand: Springer
Price: 108.0 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days • 84 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 84 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (67 days, 79.8%)

Price range: £107 - £108

Price levels: 2 different prices over 84 days

Description

Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment: 678 is a specialized medical resource published by Springer. This volume, part of the Advances in Experimental Medicine and Biology series, addresses the complex memory problems and cognitive deficits often experienced by patients undergoing chemotherapy. This book is compiled by expert editors who serve as professors researching the various factors that can compromise the total healing of both body and mind in this specific patient population. It provides a focused look at the neurological and cognitive challenges that impact recovery and quality of life during and after cancer treatment. Authored by Robert B. Raffa, PhD, a Professor of Pharmacology and Chair of the Department of Pharmaceutical Sciences at Temple University School of Pharmacy, this work brings academic rigor and professional expertise to the study of chemotherapy-related cognitive issues. It serves as a vital reference for medical professionals and researchers studying the intersection of pharmacology and cognitive health.

Key Features

Covers memory problems and cognitive deficits specifically related to chemotherapy treatments.

Compiled by professional editors and professors researching body and mind healing factors.

Part of the respected Advances in Experimental Medicine and Biology series (678).

Authored by Robert B. Raffa, PhD, a leading expert in Pharmacology and Pharmaceutical Sciences.

Provides specialized research on the cognitive challenges faced by the cancer patient population.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1493940996
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 23 August 2016
Listed Since: 18 June 2016

Barcode

No barcode data available

Springer Chemo Fog: Cancer Chemotherapy Cognitive Impairment

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Targeted Therapies in Oncology

Clayton's Basic Pharmacology for Nurses

Academic Press Biological Macromolecules - Biomedical Applications

Fundamentals of Medicinal Chemistry

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Interprofessional Education Toolkit: Practical Strategies for Program Design, Implementation, and Assessment

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

CRC Press Statistical Approaches in Oncology Clinical Development

Handbook of Nonprescription Drugs: An Interactive Approach to Self-care

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Neurological Complications of Systemic Cancer and Antineoplastic Therapy: 96 (Neurological Disease and Therapy)

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer

Biodiversity, Natural Products And Cancer Treatment

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Phase I Oncology Drug Development

Pharmaceutical Dosage Forms - Parenteral Medications: Volume 3: Regulations, Validation and the Future

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)